Chr | NA |
start | NA |
end | NA |
ID | NA |
miRNA_name | hsa-miR-105 |
methods | qRT-PCR,etc |
regulated | up |
Function Description | Results:Before neoadjuvant therapy, exosomal miRNA-21 and 105 expression levels were higher in metastaticversus non-metastatic patients and healthy donors. Likewise, higher levels of miRNA-222 were observed in basal-like(p= 0.037) and in luminal B versus luminal A (p= 0.0145) tumor subtypes. Exosomal miRNA-222 levels correlatedwith clinical and pathological variables such as progesterone receptor status (p= 0.017) and Ki67 (p= 0.05). Duringneoadjuvant treatment, exosomal miRNA-21 expression levels directly correlated with tumor size (p= 0.039) andinversely with Ki67 expression (p= 0.031). Finally, higher levels of exosomal miRNA-21, miRNA-222, and miRNA-155were significantly associated with the presence of circulating tumor cells.Conclusion:Liquid biopsies based on exosomal miRNAs and circulating tumor cells can be a complementaryclinical tool for improving breast cancer diagnosis and prognosis |
PMID | 30728048 |
year | 2019 |
Title | Exosomal miRNA profile as complementarytool in the diagnostic and prediction oftreatment response in localized breastcancer under neoadjuvant chemotherapy |
drug | X |
circulating | V |
survival | X |
CopyRight © University of Miami, USA; Harbin Medical University, China